Yuya Aono

796 total citations
45 papers, 521 citations indexed

About

Yuya Aono is a scholar working on Pulmonary and Respiratory Medicine, Mechanical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yuya Aono has authored 45 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Mechanical Engineering and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yuya Aono's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac Arrhythmias and Treatments (6 papers). Yuya Aono is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac Arrhythmias and Treatments (6 papers). Yuya Aono collaborates with scholars based in Japan, Netherlands and United Kingdom. Yuya Aono's co-authors include K. Kitajima, E. Kuramoto, Hiroshi Noguchi, Takafumi Suda, Min Suk Kang, Tomoyuki Fujisawa, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi and Yutaro Nakamura and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Stroke.

In The Last Decade

Yuya Aono

42 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuya Aono Japan 15 159 139 81 72 70 45 521
Takehisa Abe Japan 12 29 0.2× 259 1.9× 48 0.6× 40 0.6× 127 1.8× 34 495
Hidehito Kimura Japan 12 92 0.6× 22 0.2× 109 1.3× 21 0.3× 33 0.5× 63 522
Hiroshi Furuhata Japan 16 143 0.9× 164 1.2× 8 0.1× 28 0.4× 53 0.8× 56 928
Poirier United Kingdom 8 28 0.2× 110 0.8× 49 0.6× 127 1.8× 104 1.5× 16 473
Jeffrey Lu United States 7 29 0.2× 53 0.4× 55 0.7× 13 0.2× 42 0.6× 14 324
Lisa Gordon United States 10 46 0.3× 70 0.5× 13 0.2× 26 0.4× 24 0.3× 17 284
Dilek Güven Türkiye 15 35 0.2× 19 0.1× 19 0.2× 16 0.2× 111 1.6× 87 864
Ping Xu China 12 106 0.7× 30 0.2× 14 0.2× 10 0.1× 23 0.3× 38 491
Takehiro Shimada Japan 10 30 0.2× 51 0.4× 27 0.3× 12 0.2× 61 0.9× 39 421

Countries citing papers authored by Yuya Aono

Since Specialization
Citations

This map shows the geographic impact of Yuya Aono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuya Aono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuya Aono more than expected).

Fields of papers citing papers by Yuya Aono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuya Aono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuya Aono. The network helps show where Yuya Aono may publish in the future.

Co-authorship network of co-authors of Yuya Aono

This figure shows the co-authorship network connecting the top 25 collaborators of Yuya Aono. A scholar is included among the top collaborators of Yuya Aono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuya Aono. Yuya Aono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aono, Yuya, et al.. (2025). Predictive risk factors of treatment-refractory Mycobacterium avium complex lung disease: a single-center retrospective cohort study. Therapeutic Advances in Infectious Disease. 12. 2038566492–2038566492. 1 indexed citations
2.
3.
Suzuki, Yuzo, Ryo Horiguchi, Yuya Aono, et al.. (2024). CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. The Journal of Immunology. 212(7). 1221–1231. 3 indexed citations
4.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2022). Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis. Thorax. 77(7). 727–730. 20 indexed citations
5.
Aono, Yuya, Yuzo Suzuki, Ryo Horiguchi, et al.. (2022). CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology. 68(2). 201–212. 10 indexed citations
6.
Enomoto, Noriyuki, Yuko Tanaka, Yuya Aono, et al.. (2022). Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases. BMC Pulmonary Medicine. 22(1). 387–387. 10 indexed citations
7.
Aono, Yuya, Hironao Hozumi, Masato Kono, et al.. (2022). Prognostic significance of radiological pleuroparenchymal fibroelastosis inMycobacterium aviumcomplex lung disease: a multicentre retrospective cohort study. Thorax. 78(8). 825–834. 8 indexed citations
8.
Suzuki, Yuzo, Yuya Aono, Ryo Horiguchi, et al.. (2022). Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma. Autophagy. 18(9). 2216–2228. 27 indexed citations
9.
Enomoto, Noriyuki, Hironao Hozumi, Yuya Aono, et al.. (2021). Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis. Respiratory Investigation. 59(6). 827–836. 17 indexed citations
10.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2021). Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis. Scientific Reports. 11(1). 18579–18579. 11 indexed citations
11.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2021). Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study. BMC Pulmonary Medicine. 21(1). 221–221. 15 indexed citations
12.
Ikeda, Syuhei, Yoshimori An, Yuya Aono, et al.. (2020). Iatrogenic ventricular fibrillation caused by inappropriately synchronized cardioversion in a patient with pre-excited atrial fibrillation: A case report. Journal of Cardiology Cases. 23(1). 31–34.
13.
Aono, Yuya, Yasuhiro Hamatani, Nagaaki Katoh, et al.. (2020). Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) <i>Transthyretin</i> Variant. Internal Medicine. 60(4). 557–561. 2 indexed citations
14.
Abe, Mitsuru, Nobutoyo Masunaga, Mitsuru Ishii, et al.. (2019). Current status of percutaneous coronary intervention in patients with atrial fibrillation: The Fushimi AF Registry. Journal of Cardiology. 75(5). 513–520. 1 indexed citations
15.
Doi, Kosuke, Mitsuru Ishii, Yuya Aono, et al.. (2019). Spontaneous coronary artery dissection in a woman undergoing pseudomenopause therapy with leuprorelin: A case report. Journal of Cardiology Cases. 20(1). 8–10. 6 indexed citations
16.
An, Yoshimori, Hisashi Ogawa, Masahiro Esato, et al.. (2019). Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry). The American Journal of Cardiology. 124(9). 1420–1429. 14 indexed citations
17.
Nozawa, Masafumi, et al.. (2009). Serum selenium and risk of prostate cancer in Japanese men. Journal of Clinical Oncology. 27(15_suppl). e16166–e16166. 1 indexed citations
18.
Kang, Min Suk, Yuya Aono, & Hiroshi Noguchi. (2007). Effect of prestrain on and prediction of fatigue limit in carbon steel. International Journal of Fatigue. 29(9-11). 1855–1862. 31 indexed citations
19.
20.
Sumikawa, Koji, et al.. (1992). REDUCTION IN VECURONIUM INFUSION DOSE REQUIREMENTS BY DILTIAZEM IN HUMANS. Anesthesiology. 77(Supplement). A939–A939.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takehisa Abe Breakdown of academic impact, for papers by Hidehito Kimura Breakdown of academic impact, for papers by Hiroshi Furuhata Breakdown of academic impact, for papers by Poirier Breakdown of academic impact, for papers by Jeffrey Lu Breakdown of academic impact, for papers by Lisa Gordon Breakdown of academic impact, for papers by Dilek Güven Breakdown of academic impact, for papers by Ping Xu Breakdown of academic impact, for papers by Takehiro Shimada
Rankless by CCL
2026